Selectivity of small molecule ligands for parallel and anti-parallel DNA G-quadruplex structures

Org Biomol Chem. 2009 Oct 21;7(20):4194-200. doi: 10.1039/b910505k. Epub 2009 Aug 14.

Abstract

We report CD, ESI-MS and molecular modelling studies of ligand binding interactions with DNA quadruplex structures derived from the human telomeric repeat sequence (h-Tel) and the proto-oncogenic c-kit promoter sequence. These sequences form anti-parallel (both 2 + 2 and 3 + 1) and parallel conformations, respectively, and demonstrate distinctively different degrees of structural plasticity in binding ligands. With h-Tel, we show that an extended heteroaromatic 1,4-triazole (TRZ), designed to exploit pi-stacking interactions and groove-specific contacts, shows some selectivity for parallel folds, however, the polycyclic fluorinated acridinium cation (RHPS4), which is a similarly potent telomerase inhibitor, shows selectivity for anti-parallel conformations implicating favourable interactions with lateral and diagonal loops. In contrast, the unique c-kit parallel-stranded quadruplex shows none of the structural plasticity of h-Tel with either ligand. We show by quantitative ESI-MS analysis that both sequences are able to bind a ligand on either end of the quadruplex. In the case of h-Tel the two sites have similar affinities, however, in the case of the c-kit quadruplex the affinities of the two sites are different and ligand-dependent. We demonstrate that two different small molecule architectures result in significant differences in selectivity for parallel and anti-parallel quadruplex structures that may guide quadruplex targeted drug-design.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acridines / chemistry*
  • Acridines / pharmacology*
  • Circular Dichroism
  • DNA / chemistry*
  • DNA / metabolism
  • Enzyme Inhibitors / chemistry
  • Enzyme Inhibitors / pharmacology
  • G-Quadruplexes / drug effects*
  • Humans
  • Ligands
  • Mass Spectrometry
  • Molecular Dynamics Simulation
  • Proto-Oncogene Proteins c-kit / genetics
  • Substrate Specificity
  • Telomerase / antagonists & inhibitors
  • Telomere / genetics
  • Triazoles / chemistry*
  • Triazoles / pharmacology*

Substances

  • 3,11-difluoro-6,8,13-trimethyl-8H-quino(4,3,2-kl)acridinium
  • Acridines
  • Enzyme Inhibitors
  • Ligands
  • Triazoles
  • DNA
  • Proto-Oncogene Proteins c-kit
  • Telomerase